44 related articles for article (PubMed ID: 15980977)
21. Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.
Broniscer A; Chintagumpala M; Fouladi M; Krasin MJ; Kocak M; Bowers DC; Iacono LC; Merchant TE; Stewart CF; Houghton PJ; Kun LE; Ledet D; Gajjar A
J Neurooncol; 2006 Feb; 76(3):313-9. PubMed ID: 16200343
[TBL] [Abstract][Full Text] [Related]
22. Primary diffuse leptomeningeal gliomatosis.
Jicha GA; Glantz J; Clarke MJ; Lehwald LM; Russo DP; Giannini C; Wald JT; Uhm J; Kumar N; Aksamit AJ; Wetmore CJ
Eur Neurol; 2009; 62(1):16-22. PubMed ID: 19407451
[TBL] [Abstract][Full Text] [Related]
23. Heterotopic glial nests in the subarachnoid space; histopathologic characteristics, mode of origin and relation to meningeal gliomas.
COOPER IS; KERNOHAN JW
J Neuropathol Exp Neurol; 1951 Jan; 10(1):16-29. PubMed ID: 14804124
[No Abstract] [Full Text] [Related]
24. Oligodendrogliomatosis with intracranial hypertension.
KOREIN J; FEIGIN I; SHAPIRO MF
Neurology; 1957 Aug; 7(8):589-94. PubMed ID: 13451895
[No Abstract] [Full Text] [Related]
25. Primary diffuse leptomeningeal gliomatosis.
Corsten LA; Raja AI; Wagner FC
Br J Neurosurg; 2001 Feb; 15(1):62-6. PubMed ID: 11303666
[TBL] [Abstract][Full Text] [Related]
26. Primary multifocal leptomeningeal gliomatosis.
Tsui EY; Loo KT; Mok CK; Yuen MK; Cheung YK
Eur J Radiol; 2001 Jan; 37(1):5-7. PubMed ID: 11274832
[TBL] [Abstract][Full Text] [Related]
27. Primary diffuse leptomeningeal gliomatosis predominantly affecting the spinal cord: case report and review of the literature.
Baborie A; Dunn EM; Bridges LR; Bamford JM
J Neurol Neurosurg Psychiatry; 2001 Feb; 70(2):256-8. PubMed ID: 11160482
[TBL] [Abstract][Full Text] [Related]
28. Primary diffuse leptomeningeal gliomatosis: unusual MRI with non-enhancing nodular lesions on the cerebellar surface and spinal leptomeningeal enhancement.
Kastenbauer S; Danek A; Klein W; Yousry TA; Bise K; Reifenberger G; Pfister HW
J Neurol Neurosurg Psychiatry; 2000 Sep; 69(3):385-8. PubMed ID: 10945815
[TBL] [Abstract][Full Text] [Related]
29. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse.
Yung WK; Albright RE; Olson J; Fredericks R; Fink K; Prados MD; Brada M; Spence A; Hohl RJ; Shapiro W; Glantz M; Greenberg H; Selker RG; Vick NA; Rampling R; Friedman H; Phillips P; Bruner J; Yue N; Osoba D; Zaknoen S; Levin VA
Br J Cancer; 2000 Sep; 83(5):588-93. PubMed ID: 10944597
[TBL] [Abstract][Full Text] [Related]
30. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.
Yung WK; Prados MD; Yaya-Tur R; Rosenfeld SS; Brada M; Friedman HS; Albright R; Olson J; Chang SM; O'Neill AM; Friedman AH; Bruner J; Yue N; Dugan M; Zaknoen S; Levin VA
J Clin Oncol; 1999 Sep; 17(9):2762-71. PubMed ID: 10561351
[TBL] [Abstract][Full Text] [Related]
31. Survival of patients with high grade glioma treated with intrathecal thiotriethylenephosphoramide for ependymal or leptomeningeal gliomatosis.
Witham TF; Fukui MB; Meltzer CC; Burns R; Kondziolka D; Bozik ME
Cancer; 1999 Oct; 86(7):1347-53. PubMed ID: 10506724
[TBL] [Abstract][Full Text] [Related]
32. Aggressive treatment with complete remission in primary diffuse leptomeningeal gliomatosis--a case report.
Beauchesne P; Pialat J; Duthel R; Barral FG; Clavreul G; Schmitt T; Laurent B
J Neurooncol; 1998 Apr; 37(2):161-7. PubMed ID: 9524095
[TBL] [Abstract][Full Text] [Related]
33. Primary diffuse leptomeningeal gliomatosis in children: a clinical pathologic correlation.
Bernardini FP; Croxatto JO; Nozza P; Rossi A; Capris P
Ophthalmic Plast Reconstr Surg; 2013; 29(2):93-7. PubMed ID: 23247038
[TBL] [Abstract][Full Text] [Related]
34. Current and future developments in the use of temozolomide for the treatment of brain tumours.
Stupp R; Gander M; Leyvraz S; Newlands E
Lancet Oncol; 2001 Sep; 2(9):552-60. PubMed ID: 11905710
[TBL] [Abstract][Full Text] [Related]
35. Temozolomide in malignant gliomas: current use and future targets.
Villano JL; Seery TE; Bressler LR
Cancer Chemother Pharmacol; 2009 Sep; 64(4):647-55. PubMed ID: 19543728
[TBL] [Abstract][Full Text] [Related]
36. Temozolomide and treatment of malignant glioma.
Friedman HS; Kerby T; Calvert H
Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
[TBL] [Abstract][Full Text] [Related]
37. Primary diffuse leptomeningeal gliomatosis (PDLG): a neoplastic cause of chronic meningitis.
Dietrich PY; Aapro MS; Rieder A; Pizzolato GP
J Neurooncol; 1993 Mar; 15(3):275-83. PubMed ID: 8360714
[TBL] [Abstract][Full Text] [Related]
38. Neurosurgical interventions for leptomeningeal tumor.
Greenfield JP; Bilsky MH
Cancer Treat Res; 2005; 125():107-19. PubMed ID: 16211886
[TBL] [Abstract][Full Text] [Related]
39. Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosis.
Franceschi E; Cavallo G; Scopece L; Esposti RD; Paioli G; Paioli A; Palmerini E; Foschini MP; Marliani AF; Crinò L
J Neurooncol; 2005 Jul; 73(3):261-4. PubMed ID: 15980977
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
